OTCMKTS:EMMA Emmaus Life Sciences (EMMA) Stock Price, News & Analysis $0.07 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.07▼$0.0750-Day Range$0.07▼$0.1052-Week Range$0.05▼$0.28VolumeN/AAverage Volume8,307 shsMarket Capitalization$4.55 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Emmaus Life Sciences alerts: Email Address Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. About Emmaus Life Sciences Stock (OTCMKTS:EMMA)Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.Read More EMMA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EMMA Stock News HeadlinesJuly 23 at 4:23 PM | finanznachrichten.deEmmaus Life Sciences, Inc.: Emmaus Life Sciences Announces Willis C. Lee as Chief Executive OfficerJuly 23 at 10:00 AM | prnewswire.comEmmaus Life Sciences Announces Willis C. Lee as Chief Executive OfficerJuly 26, 2024 | Crypto 101 Media (Ad)Brace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.July 23 at 6:33 AM | msn.comScientists Detect Chemical Signature of Life in Clouds of Venus AgainJuly 23 at 6:33 AM | bizjournals.comEmeryville's life sciences vacancy rate skyrockets to 37%July 21, 2024 | msn.comSigns of life could survive on solar system moons Enceladus and EuropaJuly 20, 2024 | msn.comSignatures of life could survive near surfaces of the moons Enceladus and Europa, NASA experiment suggestsJuly 20, 2024 | msn.comCould blocking this one protein extend human life span?July 26, 2024 | Crypto 101 Media (Ad)Brace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.July 12, 2024 | prnewswire.comEmmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance ProgramJuly 3, 2024 | prnewswire.comEmmaus Life Sciences Reports 2023 Financial ResultsMay 28, 2024 | msn.comMSU students win Student Emmy for documentary about Dickerson Park Zoo medicineMay 26, 2024 | msn.comEmmaus' Moore rallies for second straight state long jump crownMay 9, 2024 | msn.comEmmaus boys lacrosse passes physical test from Central Catholic, moves on to EPC championshipMay 6, 2024 | msn.comWhen the eclipse illuminates: Emmaus sheds light on Erie poverty, possible solutionsMay 2, 2024 | yahoo.comEmmaus receives $250,000 Anderson grant for remodelingMay 2, 2024 | msn.comEmmaus boys lacrosse takes control in 2nd quarter, dominates rival ParklandApril 30, 2024 | yahoo.comDurham's Museum Of Life And Science Celebrates Birth Of 7 Endangered Red Wolf PupsSee More Headlines Receive EMMA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/02/2024Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:EMMA CUSIPN/A CIK822370 Webwww.emmausmedical.com Phone(310) 214-0065Fax866-294-2611Employees54Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,730,000.00 Net Margins-12.61% Pretax MarginN/A Return on EquityN/A Return on Assets-7.63% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$29.60 million Price / Sales0.15 Cash FlowN/A Price / Cash FlowN/A Book Value($0.69) per share Price / Book-0.10Miscellaneous Outstanding Shares63,870,000Free Float41,513,000Market Cap$4.55 million OptionableNot Optionable Beta1.66 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Willis C. Lee M.S. (Age 64)Co-President, COO & Chairman of the Board Comp: $240kMr. Yasushi Nagasaki CPA (Age 57)CPA, Chief Financial Officer Comp: $250kMr. George Sekulich (Age 58)Co-President, Chief Commercial Officer & Director Mr. Dale E. Short J.D.Legal Consultant & Corporate SecretaryDr. Charles W. Stark Pharm.D (Age 69)Pharm.D., Senior Vice President of Medical Affairs, Clinical, Regulatory Mr. Kurt H. Kruger M.B.A. (Age 69)M.S., Consultant Comp: $300.02kMore ExecutivesKey CompetitorsJanoneNASDAQ:ALTSIndaptus TherapeuticsNASDAQ:INDPAptorum GroupNASDAQ:APMVBI VaccinesNASDAQ:VBIVAytu BioPharmaNASDAQ:AYTUView All Competitors EMMA Stock Analysis - Frequently Asked Questions How have EMMA shares performed this year? Emmaus Life Sciences' stock was trading at $0.1001 at the start of the year. Since then, EMMA shares have decreased by 28.8% and is now trading at $0.0713. View the best growth stocks for 2024 here. How were Emmaus Life Sciences' earnings last quarter? Emmaus Life Sciences, Inc. (OTCMKTS:EMMA) issued its quarterly earnings results on Tuesday, July, 2nd. The company reported $0.02 earnings per share (EPS) for the quarter. The business earned $7.07 million during the quarter. How do I buy shares of Emmaus Life Sciences? Shares of EMMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EMMA) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EMMA Stock Alerts